DEVELOPMENT OF A PROLONGD RELEASE GASTRORETENTIVE TABLET FORMULATION OF LEVOFLOXACIN
Objective: The present investigation concerns the design and evaluation of floating tablets of Levofloxacin, which after oral administration prolong the gastric residence time and increased drug bioavailability.
Methods: Levofloxacin is a synthetic chemotherapeutic agent used to treat severe or life-threatening bacterial infections. The present work was designed to formulate floating tablet of Levofloxacin with various swelling agents. Formulations were prepared using various concentrations of Guar gum, Carbopol, hydroxy propyl methyl cellulose and Ethyl Cellulose by direct compression technique. The selected batches were evaluated for various parameters like weight variation, thickness, diameter, friability, floating lag time, duration of floating, swelling index, content uniformity and in-vitro drug release. The data obtained from the in-vitro dissolution studies of optimized batch F7 were fitted in different models.
Results: The optimized formulation F7 showed 99.25% drug content, floating lag time of 10 min and swelling index of 40%. Drug release mechanism was found to be zero order along with higuchi release kinetics exhibiting diffusion along with dissolution of the drug from the tablet by non fickian mechanism.
Conclusion: Levofloxacin floating tablets exhibited increased gastric residence time, there by improved bioavailability and therapeutic effect of the drug.Keywords: Levofloxacin, Gastro retentive, Guar gum, Hydroxy propyl methyl cellulose, Ethyl Cellulose, Carbopol.
2. Vyas SP, Khar RK. Controlled drug delivery: concepts and advances. 1st ed. Vallabh prakashan, New Delhi; 2002. p. 345-76.
3. Yeole PG. Floating drug delivery system: need and development. Indian J Pharm Sci 2005:67;265-72.
4. Shweta Aurora. Floating drug delivery: a review. AAPS Pharm Sci Tech 2005:47;268-72.
5. Thakkar VT, Shah PA, Soni TG, Parmar MY, Gohel MC, Gandhi TR. Fabrication and evaluation of Levofloxacin hemihydrates floating tablets. Res Pharm Sci 2008;3:1-8.
6. Nelson JM, Chiller TM, Powers JH, Angulo FJ. Fluoroquinolone-resistant campylobacter species and the withdrawal of fluoroquinolone from use in poultry: a public health success story. Clin Infect Dis 2007;44:977â€“80.
7. Md Ismail M, Dehghan MH, Shaikh A, Sahuji T, Chudiwal P. Preparation of a novel floating ring capsule-type dosage form for stomach specific delivery. Saudi Pharm J 2011;19:85â€“93.
8. Desai S, Bolton S. A floating controlled release system: in-vitro and in-vivo evaluation. J Pharm Res 1993:10;1321-5.
9. Garg S, Sharma S. Gastro retentive drug delivery systems. Pharm Tech 2003;2:160-4.
10. Narendra C, Srinath MS, Babu G. Optimization of bilayer floating tablet containing nevirapine as a model drug for gastric retention. AAPS Pharm Sci Tech 2006;7:E23â€“E29.
11. Srivastava AK, Wadhwa S, Ridhurkar D, Mishra B. Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation. Drug Dev Ind Pharm 2005;31:367-74.
12. Dave BS, Amin AF, Patel MM. Gastro retentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS Pharm Sci Tech 2004;5:77-82.
13. Dalavi VV, Patel JS. Gastro retentive drug delivery system of an antiretroviral agent. Int J Pharm Tech Res 2009;1:1678-84.
14. Sivabalan M, Punitha Vani T, Phaneendhar Reddy, Vasudevaiah, Anup Jose, Nigila G. Formulation and evaluation of gastro retentive glipizide floating tablets. Int J Comprehensive Pharm 2011;1:1-4.